Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of tranexamic acid administration in traumatic femoral surgery
IRCT20190325043107N90Phase 3Recruiting
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of tranexamic acid in Bleeding (3 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Intraoperative bleeding. Started Oct 2026; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
Bleeding
Beyond the preview
Go deeper on IRCT20190325043107N90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N90.